全文获取类型
收费全文 | 1031篇 |
免费 | 76篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 73篇 |
妇产科学 | 9篇 |
基础医学 | 108篇 |
口腔科学 | 43篇 |
临床医学 | 137篇 |
内科学 | 234篇 |
皮肤病学 | 24篇 |
神经病学 | 35篇 |
特种医学 | 193篇 |
外科学 | 69篇 |
综合类 | 37篇 |
预防医学 | 69篇 |
眼科学 | 16篇 |
药学 | 49篇 |
中国医学 | 1篇 |
肿瘤学 | 33篇 |
出版年
2022年 | 4篇 |
2021年 | 16篇 |
2020年 | 11篇 |
2019年 | 17篇 |
2018年 | 26篇 |
2017年 | 18篇 |
2016年 | 16篇 |
2015年 | 21篇 |
2014年 | 21篇 |
2013年 | 36篇 |
2012年 | 32篇 |
2011年 | 30篇 |
2010年 | 55篇 |
2009年 | 54篇 |
2008年 | 23篇 |
2007年 | 30篇 |
2006年 | 25篇 |
2005年 | 48篇 |
2004年 | 19篇 |
2003年 | 8篇 |
2002年 | 15篇 |
2001年 | 23篇 |
2000年 | 18篇 |
1999年 | 28篇 |
1998年 | 49篇 |
1997年 | 49篇 |
1996年 | 60篇 |
1995年 | 42篇 |
1994年 | 42篇 |
1993年 | 36篇 |
1992年 | 19篇 |
1991年 | 22篇 |
1990年 | 11篇 |
1989年 | 26篇 |
1988年 | 45篇 |
1987年 | 20篇 |
1986年 | 16篇 |
1985年 | 28篇 |
1984年 | 8篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 6篇 |
1976年 | 12篇 |
1975年 | 3篇 |
1967年 | 2篇 |
1966年 | 3篇 |
1963年 | 2篇 |
排序方式: 共有1142条查询结果,搜索用时 15 毫秒
51.
52.
53.
Kim D Harrison Beverly D Hiebert Arash Panahifar Janna M Andronowski Amir M Ashique Gavin A King Terra Arnason Kurtis J Swekla Peter Pivonka David ML Cooper 《Journal of bone and mineral research》2020,35(11):2211-2228
Cortical bone porosity is intimately linked with remodeling, is of growing clinical interest, and is increasingly accessible by imaging. Thus, the potential of animal models of osteoporosis (OP) to provide a platform for studying how porosity develops and responds to interventions is tremendous. To date, rabbit models of OP have largely focused on trabecular microarchitecture or bone density; some such as ovariectomy (OVX) have uncertain efficacy and cortical porosity has not been extensively reported. Our primary objective was to characterize tibial cortical porosity in rabbit-based models of OP, including OVX, glucocorticoids (GC), and OVX + GC relative to controls (SHAM). We sought to: (i) test the hypothesis that intracortical remodeling is elevated in these models; (ii) contrast cortical remodeling and porosity in these models with that induced by parathyroid hormone (1–34; PTH); and (iii) contrast trabecular morphology in the proximal tibia across all groups. Evidence that an increase in cortical porosity occurred in all groups was observed, although this was the least robust for GC. Histomorphometric measures supported the hypothesis that remodeling rate was elevated in all groups and also revealed evidence of uncoupling of bone resorption and formation in the GC and OVX + GC groups. For trabecular bone, a pattern of loss was observed for OVX, GC, and OVX + GC groups, whereas the opposite was observed for PTH. Change in trabecular number best explained these patterns. Taken together, the findings indicated rabbit models provide a viable and varied platform for the study of OP and associated changes in cortical remodeling and porosity. Intriguingly, the evidence revealed differing effects on the cortical and trabecular envelopes for the PTH model. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).. 相似文献
54.
55.
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B 总被引:121,自引:0,他引:121
Villeneuve JP Condreay LD Willems B Pomier-Layrargues G Fenyves D Bilodeau M Leduc R Peltekian K Wong F Margulies M Heathcote EJ 《Hepatology (Baltimore, Md.)》2000,31(1):207-210
The prognosis of decompensated cirrhosis resulting from chronic hepatitis B is poor, and the benefits of treatment with interferon are outweighed by serious side effects and by the risk of fatal exacerbation of disease activity. Lamivudine rapidly reduces hepatitis B virus (HBV)-DNA in serum to undetectable levels. We have treated 35 patients with chronic hepatitis B and decompensated cirrhosis with lamivudine 100 mg or 150 mg orally once daily. Pretreatment, all were positive for HBV-DNA in serum. Ten had Child-Pugh class B and 25 had Child-Pugh class C liver disease. Seven patients underwent liver transplantation within 6 months of treatment initiation, 5 patients died within 6 months, and 23 patients were treated for at least 6 months (mean = 19 months). In a majority of these 23 cases, there was a slow but marked improvement in liver function, which was most apparent after 9 months of treatment, with a decrease in serum bilirubin from 67 +/- 13 to 30 +/- 4 micromol/L (P <.05, baseline vs. 9 months), an increase in serum albumin from 27 +/- 1 to 34 +/- 1g/L (P <.05), and a decrease in Child-Pugh score from 10.3 +/- 0.4 to 7.5 +/- 0.5 (P <.05). Three patients developed resistance to lamivudine because of a mutation in the YMDD motif, but liver function did not deteriorate. We conclude that inhibition of viral replication with lamivudine results in a significant improvement of liver function in patients with decompensated HBV cirrhosis, but the long-term benefits remain uncertain. 相似文献
56.
Auber ML; Horwitz LJ; Blaauw A; Khorana S; Tucker S; Woods T; Warmuth M; Dicke KA; McCredie KB; Spitzer G 《Blood》1988,71(1):166-172
Relatively nonmyelotoxic drugs and drug combinations were investigated for their ability to eliminate malignant cells from human bone marrow. In vitro 90% inhibitory concentration (IC90) doses were established on granulocyte macrophage colony-forming units (GM-CFU) in culture of bone marrow by using the GM-CFU assay for the following drugs: 4- hydroperoxycyclophosphamide (4-HC), Adriamycin, L-asparaginase, bleomycin, hydrocortisone, VP-16, spirogermanium, Taxol, and vincristine. The leukemic cell kill efficiency of these drugs at IC90 doses was compared with that of 4-HC on acute lymphoid leukemia (ALL) cell lines by using the limiting-dilution assay. Under these conditions, no single drug was superior to 4-HC. To increase the in vitro effect in leukemic cell kill, combinations of vincristine with hydrocortisone, Adriamycin, VP-16, and 4-HC were investigated. Vincristine at 1 to 5 micrograms/mL increased the marrow cytotoxicity of hydrocortisone, Adriamycin, and VP-16, but it was protective (subadditive) with 4-HC. Vincristine and 4-HC in combination was additive to supraadditive on ALL cell lines, increased the leukemic cell kill by one to two logs above 4-HC alone at IC90 doses (P less than .05), and was not affected by the addition of excess marrow cells. The recommended doses for chemopurging in clinical studies are vincristine, 1 to 5 micrograms/mL, plus 4-HC, 5 micrograms/mL. 相似文献
57.
58.
Elizabeth A. Bilodeau Joanne L. Prasad Faizan Alawi Raja R. Seethala 《Head and neck pathology》2014,8(4):400-410
In this article we outline the molecular findings of select odontogenic tumors. In each section, we briefly review selected the clinicoradiographic, histologic, immunologic features, focusing on the molecular findings and their applications in practice. The understanding of molecular pathobiology at various other organ sites has developed quite rapidly in recent years, however much remains unknown about the genetic profile of odontogenic tumors. Improved understanding of mutations in odontogenic tumors may clarify classification schema and elucidate targets for novel therapies. Molecular testing will no doubt improve our understanding of odontogenic tumor pathogenesis and will likely be, someday, an important component of routine clinical practice and its role will only increase in the coming years. 相似文献
59.
60.
Claudia Bilodeau Olivia Goltsis Ian M. Rogers Martin Post 《Journal of tissue engineering and regenerative medicine》2020,14(3):521-538
A shortage of donor organs for transplantation and the dependence of the recipients on immunosuppressive therapy have motivated researchers to consider alternative regenerative approaches. The answer may reside in acellular scaffolds generated from cadaveric human and animal tissues. Acellular scaffolds are expected to preserve the architectural and mechanical properties of the original organ, permitting cell attachment, growth, and differentiation. Although theoretically, the use of acellular scaffolds for transplantation should pose no threat to the recipient's immune system, experimental data have revealed significant immune responses to allogeneic and xenogeneic transplanted scaffolds. Herein, we review the various factors of the scaffold that could trigger an inflammatory and/or immune response, thereby compromising its use for human transplant therapy. In addition, we provide an overview of the major cell types that have been considered for recellularization of the scaffold and their potential contribution to triggering an immune response. 相似文献